Chinese Bio-pharma firm to authorize recombinant arthritis biosimilar drug in Singapore

China |  News | 0 Comment | 27 Aug, 2021

Mabwell (Shanghai) Bioscience Co. Ltd and Singapore's FEGO Biotech Pte Ltd have jointly entered into a co...Read more

Chinese startups advance drug discovery for neurodegenerative diseases

China |  News | 0 Comment | 27 Aug, 2021

China-based startups Insilico Medicine and 4B Technologies have signed a strategic collaboration agreement in ...Read more

Wockhardt Bio partners with China-based Jemincare for pneumonia drug

China |  News | 0 Comment | 26 Aug, 2021

Wockhardt Bio, a subsidiary of Wockhardt, a leader in the discovery of novel antibiotics and Jiangxi Jemincare Group Com...Read more

Chinese pharma to commercialize Proxalutamide for COVID-19 treatment in Indonesia

China |  News | 0 Comment | 26 Aug, 2021

Kintor Pharmaceutical Limited, a clinical-stage biotechnology company developing innovative small molecule and biologica...Read more

China approves NGS-based genomic alteration tumour test by OrigiMed & Bayer

China |  News | 0 Comment | 23 Aug, 2021

OrigiMed has announced that the Human NTRK1/2/3 Genomic Alteration Testing Kit has been granted the Special Review ...Read more

China develops new real-time RT-PCR assays to detect SARS-CoV-2 variants

China |  News | 0 Comment | 20 Aug, 2021

With the ongoing worldwide COVID-19 pandemic, an increasing number of viral variants are being identified, which poses a...Read more

Domestic pharma firms lead CAR-T therapy trials in China, GlobalData

China |  Analysis | 4 Comment | 19 Aug, 2021

China’s overall focus within oncology research is increasing at a rapid pace. Moreover, the country recently appro...Read more

China completes largest ever dry eye disease clinical trial

China |  News | 1 Comment | 19 Aug, 2021

Zhaoke Ophthalmology has announced that the Phase III clinical trial of one of the company's core drug candidates, Cyclo...Read more

Hong Kong offers genome-editing strategy to fight Alzheimer’s Disease

China |  News | 0 Comment | 17 Aug, 2021

An international research team led by scientists from the Hong Kong University of Science and Technology (HKUST) has dev...Read more

China approves GC Pharma's GreenGene F as a therapy to treat Haemophilia A

China |  News | 0 Comment | 12 Aug, 2021

China National Medical Products Administration (NMPA) has approved GC Pharma's GreenGene F (Beroctocog alfa) [Recom...Read more

USFDA grants EUA to Hong Kong's INDICAID COVID-19 Rapid Antigen Test

China |  News | 0 Comment | 11 Aug, 2021

Hong Kong-based PHASE Scientific International has announced that its INDICAID™ COVID-19 Rapid Antigen Test (...Read more

First rapid at-home diagnostic test for COVID-19 enters Asia

China |  News | 0 Comment | 10 Aug, 2021

Hong Kong-based New World Development (NWD) and Prenetics have jointly announced the launch of the Circle HealthPod...Read more

China discovers effective weight-loss method

China |  News | 0 Comment | 09 Aug, 2021

A collaborative study between scientists at the Shanghai University of Traditional Chinese Medicine and AntiCancer Inc. ...Read more

Chinese firms to advance drug development for hard-to-drug molecular targets

China |  News | 1 Comment | 09 Aug, 2021

Hong Kong's Antengene Corporation Limited, a biopharmaceutical company focused on hematology and oncology drugs is ...Read more

Promega brings MSI companion diagnostic IVD kit for cancer patients in China

China |  News | 0 Comment | 06 Aug, 2021

Shanghai Promega Biological Products and Shanghai Henlius Biotech, Inc. will develop and commercialize a microsatellite ...Read more

China identifies faecal bacterial markers for autism

China |  News | 0 Comment | 05 Aug, 2021

The Faculty of Medicine of The Chinese University of Hong Kong (CU Medicine) reports a ground breaking discove...Read more

Poland and Peru receives Micomme medical help to fight the pandemic

China |  News | 0 Comment | 05 Aug, 2021

Micomme has associated with Polish and Peruvian partners to accomplish the government centralized purchase of 1,600...Read more

WuXi STA acquires Bristol Myers Squibb's manufacturing facility in Switzerland

China |  News | 0 Comment | 03 Aug, 2021

WuXi STA – a subsidiary of WuXi AppTec – has completed the acquisition of a drug product manufacturing facil...Read more